Shuimu BioSciences

Cryo-electron microscopy (Cryo-EM) has revolutionized structural biology by enabling the determination of high-resolution 3D structures of biological macromolecules. Unlike traditional methods that require crystallization, Cryo-EM allows samples to be studied in a near-native state. Achieving high cryo-EM resolution is paramount for gaining detailed insights into the structure and function of these molecules, which is vital for life sciences and drug development. Shuimu BioSciences, founded at Tsinghua University in 2017, is a leading commercial platform in Asia offering Cryo-EM structure determination services. Their expertise and advanced technologies are dedicated to pushing the boundaries of high-resolution analysis. To explore their capabilities further, visit https://shuimubio.com/.

Understanding Cryo-EM Resolution

At its core, Cryo-EM resolution refers to the level of detail visible in the reconstructed 3D structure. Higher resolution, often measured in Ångströms (Å), means finer details of the molecule's shape can be resolved. Single Particle Analysis (SPA), a powerful approach integrating Cryo-EM, relies on collecting extensive 2D images of purified macromolecular particles and using computational algorithms for processing and reconstruction to produce a detailed 3D structural model. The goal is to achieve the highest possible cryo-EM resolution to accurately depict atomic arrangements and understand molecular interactions.

Why High-Resolution Structures are Crucial

The pursuit of high-resolution structures in Cryo-EM is driven by the need for precise information about biological molecules. Detailed 3D structures reveal how molecules interact, their conformational changes, and the mechanisms behind their functions.

For instance, in vaccine research and development, resolving the 3D structures of viruses at near-atomic resolution provides key insights for vaccine design and helps researchers understand viral entry mechanisms. Shuimu's Cryo-EM platform has been instrumental in studying viruses like SARS-CoV-2, including resolving the full-length structure of the ACE2 receptor and the spike protein in complex with ACE2, offering a crucial basis for understanding viral entry and guiding vaccine design. High-resolution analysis also allows for vaccine quality control, examining morphology, particle size, integrity, and aggregation, and clarifying how antibodies bind to vaccine antigens to optimize immunogenicity. The ability to rapidly analyze new viral variants at high resolution is critical for adjusting vaccine designs in response to mutations.

In antibody drug development, Cryo-EM plays a crucial role by revealing high-resolution 3D structures of antibody–antigen interactions. This helps researchers understand recognition mechanisms and binding sites, key information for designing more effective antibody drugs. High-resolution analysis is also used to study the mechanism of action of antibody drugs, understand how they bind to targets, and modulate signaling pathways. Analyzing existing antibody structures at high resolution can identify potential improvements, revealing dynamic processes and conformational changes to support the design of antibodies with higher affinity and specificity. Furthermore, many antibody drug targets are membrane proteins like GPCRs, and Cryo-EM can resolve their high-resolution structures, shedding light on crucial mechanisms for developing antibodies against them. The speed and clarity of Cryo-EM’s high-resolution analysis accelerate the optimization of antibody designs and overall drug development processes.

Shuimu BioSciences emphasizes the uncompromising pursuit of resolution. Their platform is purpose-built for high-resolution structural analysis, equipped with top-tier instruments and advanced computing platforms. They have resolved numerous structures at high resolution, including challenging membrane proteins, antigen-antibody complexes, and viruses. To leverage Shuimu's expertise in obtaining high-resolution structural insights for your research, visit https://shuimubio.com/.

Factors Affecting Cryo-EM Resolution

Achieving high cryo-EM resolution is not always straightforward and can be impacted by several factors. These challenges include:

· Small protein molecular weight: Smaller proteins can be harder to visualize and align precisely. Shuimu BioSciences has successfully elucidated protein structures as small as 51kDa, highlighting their expertise in handling different molecular sizes and overcoming this challenge.

· Low concentration: Samples with low particle concentration can make data collection inefficient and challenging.

· High background noise: Noise in the images can obscure fine structural details, limiting the achievable resolution.

· Air-water interface disruption: The interface between the sample solution and the air during grid preparation can cause particle denaturation or preferential orientation.

· Preferential orientation: When particles tend to lie on the grid in only a few orientations, it limits the ability to collect a complete set of views needed for 3D reconstruction, thus hindering resolution.

These factors can make obtaining high-resolution structures difficult, particularly for challenging samples like membrane proteins, small molecules, or flexible complexes. Shuimu BioSciences has developed specific technologies and workflows to address these bottlenecks and improve cryo-EM resolution. Discover how Shuimu addresses these challenges at https://shuimubio.com/.

Tactics for Improving Cryo-EM Resolution

Overcoming the limitations mentioned above requires advanced techniques, specialized equipment, and significant expertise. Shuimu BioSciences employs several strategies and proprietary technologies to enhance cryo-EM resolution:

1. Advanced Sample Preparation: Sample quality is fundamental to achieving high resolution. Shuimu provides comprehensive protein preparation and analysis services, including various expression systems (E. coli, mammalian cells, insect cells, cell-free) and purification processes (affinity, ion-exchange, gel filtration, RP-HPLC). They also offer complex incubation and size-exclusion chromatography to ensure higher purity and homogeneity. Minimizing factors like glycosylation, phosphorylation, and repeated freeze-thaw cycles are crucial for maintaining sample integrity and improving results. Their expertise in membrane protein production and purification is particularly noteworthy. For small molecules, specific requirements for purity, concentration, and solubility are critical. Proper sample preparation is the first step towards high cryo-EM resolution, and Shuimu’s integrated platform minimizes variability.

2. Specialized Grids (GraFuture™): Traditional support grids can contribute to issues like gas-liquid interface absorption, severe preferred orientation, high sample concentration threshold, significant background noise, and difficulty reconstructing small structures. To tackle the bottleneck of sample preparation and potentially solve the preferred orientation problem, Shuimu developed a series of graphene support grids called GraFuture™. These grids are suitable for applications involving samples with small protein molecular weight, low concentration, strong background noise, and susceptibility to air-water interface damage, directly addressing factors that limit cryo-EM resolution. GraFuture™ GO (Graphene oxide) and GraFuture™ RGO (Reduced graphene oxide) are available. Learn more about how GraFuture™ can improve your cryo-EM resolution results by contacting Shuimu BioSciences at https://shuimubio.com/.

3. Cutting-Edge Instrumentation and Maintenance: The quality and capabilities of the electron microscope are paramount for achieving high cryo-EM resolution. Shuimu BioSciences operates a large commercial Cryo-EM platform with 300 kV instruments in both Beijing and Hangzhou. Their Cryo-EM Center is equipped with eight electron microscopes and full supporting apparatus, including high-performance detectors, energy filters, spherical aberration, and phase plates, ensuring imaging quality to the greatest extent. Daily platform maintenance and regular, high-frequency upkeep ensure equipment is always in optimal condition, guaranteeing the efficiency and quality of data collection necessary for high resolution. Their instruments maintain over 330 days of available machine time annually with an annual fault-free operation rate greater than 97%. Experience the difference cutting-edge equipment makes to cryo-EM resolution at https://shuimubio.com/.

4. AI-Driven Data Analysis (SMART Suite, NanoSMART): Data processing and 3D reconstruction are critical steps in determining the final resolution. Shuimu utilizes proprietary AI algorithms and software suites, such as the independently developed SMART software suite, to streamline Cryo-EM data analysis and enhance efficiency and accuracy in structure determination. Their AI-driven platform reduces machine runtime and required data volume, improving the efficiency of the entire data analysis process. For Cryo-Characterization of nanoparticles like LNPs, liposomes, and AAVs, Shuimu uses NanoSMART, a self-developed AI system that automatically identifies nanoparticle features, enhances the clarity of low-quality images, and optimizes recognition results, providing detailed reports. These AI tools contribute significantly to achieving and validating high resolution.

5. Experienced Scientist Team and Advanced Workflows: The expertise of the scientific team is invaluable in navigating the complexities of Cryo-EM and achieving the best possible resolution. Shuimu's team is composed of PhD-level experts from preeminent institutions, specializing in structural biology, protein science, and computational biology. Leveraging the deep research and technical heritage at Tsinghua University, they have established efficient, advanced workflows for both experimental procedures and data analysis. Experienced technicians ensure professional operation and real-time response during data collection. This combination of expert knowledge and optimized processes is key to consistently delivering high-resolution results.

Shuimu BioSciences' Achievements in High Resolution

Shuimu BioSciences has a strong track record of achieving impressive cryo-EM resolution results, demonstrating their capability across a range of sample types:

· They have completed over 400 Cryo-EM projects and resolved more than 150 structures.

· They have achieved a best resolution of 1.8 Å using SPA.

· They have resolved structures as small as 51 kDa.

· They have pushed the boundaries of Cryo-EM technology, achieving a ground-breaking resolution of 1.4 Å.

· Their MicroED solutions, used for small molecule drugs and protein structure determination, have successfully delivered over 80% of projects, achieving resolutions of 0.6~1.0Å, which is particularly impressive for small compounds.

· Over 300 proteins have been resolved with exceptional <3.5Å resolution.

· Numerous research results supported by their platform's instruments and scientist team have been published in top international journals, resolving atomic-level resolution structures covering ion channels, GPCRs, antigen-antibody complexes, spliceosomes, and other biological samples.

These achievements highlight Shuimu's commitment to the uncompromising pursuit of resolution and their ability to provide high-quality structural information for diverse research needs. To learn more about their successful high-resolution cases, visit https://shuimubio.com/.

How Shuimu's Services Support High Resolution

Shuimu offers a range of integrated services designed to support the entire structural determination pipeline, with a focus on achieving high resolution.

· One-Stop SPA Solutions: This service is explicitly designed to unveil high-resolution 3D structures of biological macromolecules, handling diverse samples like antigen-antibody complexes, membrane proteins, viruses, and peptides. The workflow includes protein expression & purification, negative staining (for initial quality assessment), sample freezing, data collection, and AI-driven data processing (2D particle picking, 3D reconstruction, model refinement), all steps optimized for high resolution.

· Protein Preparation and Analysis: Providing high-quality, homogeneous protein samples is foundational for successful high-resolution Cryo-EM. Shuimu's platform offers molecular cloning, expression, purification, and characterization services, minimizing variability and addressing challenges posed by difficult-to-express proteins. Quality control using methods like SDS-PAGE, Western blot, and mass spectrometry ensures sample suitability for high-resolution studies.

· Instrument Access: Providing 24-hour access to state-of-the-art 300 kV Cryo-EM instruments equipped with advanced components is critical for collecting high-quality data necessary for high resolution. Their reliable access and professional service ensure researchers can perform data collection under optimal conditions.

· GraFuture™, GO & RGO: As discussed, these proprietary graphene grids are specifically designed to overcome sample preparation challenges that limit resolution, such as preferred orientation and issues with small or low-concentration samples.

· Cryo Characterization: While not focused on resolving atomic details of proteins, this service uses ultra-low temperature technology to maintain the natural state of samples like LNPs, liposomes, AAVs, and VLPs for observation and analysis. Using NanoSMART, it provides efficient and precise characterization of features like size distribution, roundness, and integrity, which are important quality attributes influencing the potential for achieving high resolution of such particles if pursued via SPA.

· MicroED Solutions: This technology excels at resolving high-resolution structures (0.6~1.0Å) from microcrystals and nanocrystals, particularly for small molecules, peptides, and protein crystals. This complements Cryo-EM SPA, offering a path to very high resolution for suitable samples.

By integrating these services, Shuimu BioSciences provides "One-Stop" solutions aimed at delivering high-resolution 3D structures from gene sequences, accelerating research and development in structural biology and drug discovery. To leverage their comprehensive services for your high-resolution needs, explore https://shuimubio.com/.

Conclusion

Achieving high cryo-EM resolution is fundamental for unlocking detailed insights into the complex world of biological macromolecules, driving advancements in drug development, vaccine research, and fundamental life sciences. While challenges such as sample quality, concentration, preferred orientation, and technical limitations exist, innovative solutions and expertise can effectively address them. Shuimu BioSciences stands at the forefront of this field, offering a comprehensive platform equipped with cutting-edge instruments, proprietary technologies like GraFuture™ and AI-driven software, and led by an elite team of scientists. Their proven track record of achieving resolutions down to 1.4 Å and handling challenging samples demonstrates their unwavering commitment to the uncompromising pursuit of resolution. By providing integrated, one-stop solutions from protein preparation to data analysis, Shuimu enables researchers worldwide to obtain the high-resolution structural data critical for their success. To benefit from their expertise and accelerate your high-resolution structural determination projects, visit https://shuimubio.com/.

 

Contact us

See Unseeable.
Drug Undruggable.

Founded in 2017, Shuimu BioSciences aims to bring the power of cryo-EM to innovative therapeutics developers.

Contacts

1 Broadway 5th floor, Cambridge, MA 02142, United States+1 (650) 680 9383

Hi@shuimubio.com

Copyright © 2026 Shuimu Biosciences Ltd.
京ICP备2020035593号